Injectable Opdivo May Mitigate Disparities in Kidney Cancer
Subcutaneous Opdivo led to similar outcomes to intravenous administration of the drug and may be easier to access down the road, an expert said.
Source: curetoday.com
Advanced Kidney News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Advanced Kidney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Advanced Kidney Today - Breaking & Trending Today
Lenvima Plus Keytruda 'Stood the Test of Time' for Kidney Cancer
Longer follow-up data showed that Lenvima plus Keytruda still outperformed Sutent in the treatment of patients with advanced renal cell carcinoma.
Source: curetoday.com
Triplet Regimen Bests Single-Agent Cabometyx in Soft Tissue Sarcoma
Adding Opdivo and Yervoy to Cabometyx led to improved progression-free survival and disease control rates in patients with soft tissue sarcoma, recent research showed.
Source: curetoday.com
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Present Extensive, Wide-Ranging New Cancer Research Data at the 2021 ASCO Annual Meeting
Share this article Share this article NEW BRUNSWICK, N.J., May 19, 2021 /PRNewswire/ -- Rutgers Cancer Institute of New Jersey, a leader in cutting-edge clinical trials and health outcomes analyses and a designated Comprehensive Cancer Center by the National Cancer Institute, together with RWJBarnabas Health, today announced that data from its cancer clinical research program will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held virtually from June 4-8. A total of 16 presentations including 13 abstracts, two educational sessions and one clinical...
Source: prnewswire.com